BiotechTube
Projections Research

Projections Research

Phoenixville, United States· Est.
pri-home.net
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 1990 and operational since 2001, Projections Research, Inc. is a privately-held consultancy providing advanced pharmacometric and modeling & simulation services to the pharmaceutical industry. The company's core expertise lies in using population PK/PD analysis and clinical trial simulation to de-risk development, identify optimal dosing, and shorten the time and cost of bringing drugs to market. Led by renowned pharmacometrician Dr. Diane Mould, PRI has established long-term partnerships with most major pharmaceutical companies and many smaller biotechs, supporting filings across multiple therapeutic areas including oncology, virology, and cardiovascular diseases.

OncologyVirologyCardiovascularInflammatory DiseasesInfectious Diseases

Technology Platform

Expertise in Model-Informed Drug Development (MIDD) using population pharmacokinetic/pharmacodynamic (PK/PD) modeling and clinical trial simulation, primarily with software like NONMEM, to optimize dosing and clinical trial design.

Opportunities

The strong regulatory push for Model-Informed Drug Development (MIDD) and the pharmaceutical industry's constant need to reduce development costs and failure rates create a growing, sustainable market for specialized pharmacometric services.
The expansion of complex biologics, targeted therapies, and personalized medicine further increases demand for sophisticated modeling to understand patient variability and optimize dosing.

Risk Factors

The business faces key person risk centered on its founder and President, and its revenue is dependent on the R&D spending cycles of the pharmaceutical industry.
Competition from other consultancies, large CROs, and internal client teams, alongside the need to integrate new computational techniques like AI/ML, presents ongoing challenges.

Competitive Landscape

PRI competes in the pharmacometrics consulting niche against other specialized firms (e.g., Certara, which also sells software), the modeling and simulation divisions of large Contract Research Organizations (CROs), and the in-house pharmacometrics teams of its own pharmaceutical clients. Its differentiation is based on deep, founder-led expertise, a long track record, and a focus on high-level strategic consulting rather than commoditized services.

More companies in Digital Health & Biotech SaaS →More companies in United States →